Magnesium sulphate: the drug of choice in eclampsiaBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7007.702 (Published 16 September 1995) Cite this as: BMJ 1995;311:702
- James P Neilson
- Professor of obstetrics and gynaecology University of Liverpool, Liverpool Women's Hospital, Liverpool L69 3BX
Definitive trial signals triumph for researchers in the developing world
Until this year, the pharmacological treatment of eclampsia has been determined largely by geography, habit, and prejudice. Magnesium sulphate has been the drug of choice in the United States; in Britain, diazepam and, more recently, phenytoin have been favoured.1 None of these choices was influenced by strong scientific evidence.
A network of researchers has recently reported the first large randomised trial comparing these three drugs in eclampsia.2 The collaborative eclampsia trial is the most important obstetric trial of the 20th century, and it has set new standards for vision and ambition in clinical trials in perinatal medicine. It included no fewer than 1680 eclamptic women recruited by local clinicians in west and southern Africa, South America, and India; and the trial was coordinated mainly by the National Perinatal …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial